RESTON, VA / ACCESSWIRE / August 3, 2018 / MMJ International Holdings, the premier medical sciences research company that is currently advancing the science of medical […]
MMJ Files FDA application to initiate clinical trials assessing the company’s cannabinoid pharmaceutical compounds for treating and/or preventing symptoms associated with multiple sclerosis (MS) has been […]